Penumbra, Inc. Profile Avatar - Palmy Investing

Penumbra, Inc.

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thromb…
Medical - Devices
US, Alameda [HQ]

Cash Flow Statements

12 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
- - -3.00 -6.00 -22.00 -12.00 12.00 28.00 26.00 -33.00 9.00 -55.00 97.00
Operating Cash (Net)
- - -3.00 -6.00 -22.00 -12.00 12.00 28.00 26.00 -33.00 9.00 -55.00 97.00
Accounts Receivable
- - -1.00 -7.00 -11.00 -14.00 -9.00 -25.00 -25.00 -8.00 -21.00 -69.00 - -
Accounts Payable
- - - - 1.00 - - 1.00 1.00 1.00 6.00 - - -1.00 13.00 1.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
- - -1.00 -37.00 -85.00 - - -77.00 - - -12.00 -104.00 -21.00 54.00 -16.00
Capital Expenditure
- - - - -3.00 -5.00 -13.00 -15.00 -9.00 -22.00 -24.00 -21.00 -19.00 -15.00
Purchases of Investments
- - -6.00 -51.00 -135.00 -63.00 -194.00 -109.00 -77.00 -153.00 -126.00 - - -81.00
Sale/Maturity of Investment
- - 6.00 18.00 54.00 77.00 141.00 139.00 95.00 76.00 123.00 74.00 82.00
Property, Plant, Equipment (P&PE)
- - - - -3.00 -5.00 -13.00 -15.00 -9.00 -22.00 -24.00 -21.00 -19.00 -15.00
Acquisitions (Net)
- - - - - - - - - - -9.00 -20.00 - - - - 2.00 - - - -
Other Investing Activities
- - - - - - - - - - - - - - -9.00 -3.00 - - 74.00 - -
Financing Activities
Used Cash (Net)
- - -2.00 -42.00 -124.00 -7.00 -104.00 -9.00 -8.00 -134.00 - - -11.00 -16.00
Debt Repayment
- - - - -6.00 - - - - -1.00 - - -2.00 -3.00 -1.00 -1.00 -1.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - 9 - - - - - - - - 27 144 29 21 16
Other Financing Activities
- - 2.00 58.00 - - - - - - -16.00 21.00 23.00 20.00 15.00 3.00
Cash Balances
Begin of Period
- - 7.00 4.00 3.00 19.00 13.00 50.00 67.00 72.00 69.00 59.00 69.00
End of Period
- - 4.00 3.00 19.00 13.00 50.00 67.00 72.00 69.00 59.00 69.00 167.00
Change
- - -3.00 - - 16.00 -6.00 37.00 17.00 4.00 -3.00 -10.00 10.00 97.00
Non-Cash Balances
Depreciation and Amortization
- - - - - - 1.00 2.00 3.00 6.00 8.00 12.00 16.00 24.00 27.00
Stock Based Compensation
- - - - 1.00 7.00 14.00 17.00 - - 21.00 25.00 65.00 37.00 50.00
Other
- - -3.00 1.00 1.00 4.00 4.00 38.00 5.00 17.00 9.00 4.00 26.00
Highlighted metrics
Free Cash Flow (FCF)
- - -4.00 -10.00 -27.00 -26.00 -2.00 19.00 4.00 -57.00 -11.00 -74.00 82.00
Cash Conversion Cycle (CCC)
- - 357.00 325.00 376.00 331.00 339.00 324.00 357.00 412.00 400.00 447.00 419.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of PEN's Analysis
CIK: 1321732 CUSIP: 70975L107 ISIN: US70975L1070 LEI: - UEI: -
Secondary Listings
PEN has no secondary listings inside our databases.